Display Options:
Total: 1404
Antibody
Investigational
Unknown
Unknown
Unknown
Interferon alpha-1/13 binding agent
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
Antibody
Investigational
Unknown
Unknown
Psoriasis
Interferon gamma inhibitor
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
Antibody
Investigational
Unknown
Unknown
Supranuclear Palsy, Progressive; Alzheimer Disease
Unknown
Antibody
Investigational
Unknown
Unknown
Spinal Cord Injuries
Reticulon-4 inhibitor
Antibody
Investigational
Unknown
Unknown
Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell
Unknown
Antibody
Investigational
Unknown
Unknown
Breast Neoplasms; Head and Neck Neoplasms; Neoplasms; Pancreatic Neoplasms
Unknown
Antibody
Investigational
Unknown
Unknown
Carcinoma, Renal Cell
CD70 antigen binding agent
Antibody
Investigational
Unknown
Unknown
Central Nervous System Neoplasms
Lewis Y antigen binding agent
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
Antibody
Investigational
Unknown
Unknown
Fallopian Tube Neoplasms; Ovarian Neoplasms; Peritoneal Neoplasms
Proheparin-binding EGF-like growth factor inhibitor
Antibody
Investigational
Unknown
Unknown
Ovarian Neoplasms; Pancreatic Neoplasms
Mucin-16 binding agent
Antibody
Investigational
Unknown
Unknown
Lymphoma
CD22 binding agent
Antibody
Unknown
Unknown
Unknown
Unknown
Unknown
Antibody
Unknown
Unknown
Unknown
Unknown
Unknown
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
Antibody
Unknown
Unknown
Unknown
Unknown
Unknown
Antibody
Investigational
Unknown
Unknown
Unknown
Glycoprotein inhibitor
Antibody
Investigational
Unknown
Unknown
Severe Combined Immunodeficiency
Stem cell growth factor receptor inhibitor
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
Antibody
Investigational
Unknown
Unknown
Unknown
Envelope polyprotein GP160 inhibitor
Antibody
Investigational
Unknown
Unknown
Breast Neoplasms; Neoplasms; Pancreatic Neoplasms
Frizzled-1 antagonist
Antibody
Investigational
Unknown
Unknown
Melanoma
5,6-dihydroxyindole-2-carboxylic acid oxidase other
Antibody
Investigational
Unknown
Unknown
Carcinoma
Epithelial cell adhesion molecule binding agent
Antibody
Investigational
Unknown
Unknown
Melanoma
Programmed cell death 1 ligand 2 cross-linking agent
Antibody
Investigational
Unknown
Unknown
Prostatic Neoplasms
Glutamate carboxypeptidase II binding agent
Antibody
Investigational
Unknown
Unknown
Dermatitis, Atopic; Rhinitis, Allergic, Seasonal
Ig epsilon chain C region inhibitor
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
Antibody
Investigational
Unknown
Unknown
Unknown
Interleukin-13 inhibitor
Antibody
Investigational
Unknown
Unknown
Lymphoma; Neoplasms
Tumor necrosis factor receptor superfamily member 8 binding agent
Antibody
Investigational
Unknown
Unknown
Leukemia, Lymphocytic, Chronic, B-Cell
Leukocyte antigen CD37 binding agent
Antibody
Investigational
Unknown
Unknown
Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant
Glutamate carboxypeptidase II binding agent